A Case of Probable MHC Class II Deficiency with Disseminated BCGitis

Iran J Immunol. 2015 Sep;12(3):219-25.

Abstract

Major histocompatibility complex (MHC) class II deficiency is a primary immunodeficiency disease characterized by abnormality of MHC class II molecules surface expression on peripheral blood lymphocytes and monocytes. Clinical manifestations include extreme susceptibility to viral, bacterial, and fungal infections but the immunodeficiency is not as severe as SCID (severe combined immunodeficiency), as evidenced by failure to develop disseminated infection after BCG vaccination. Therefore, MHC II deficiency with BCGosis, that is disseminated BCGitis, is not reported commonly. We report an interesting case of BCGosis after vaccination that was diagnosed to have probable MHC II deficiency.

Publication types

  • Case Reports

MeSH terms

  • Antitubercular Agents / administration & dosage
  • BCG Vaccine / administration & dosage*
  • BCG Vaccine / adverse effects
  • Brain / immunology
  • Brain / microbiology*
  • Female
  • Genes, MHC Class II / genetics
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / diagnosis*
  • Infant
  • Lung / immunology
  • Lung / microbiology*
  • Mycobacterium bovis / immunology*
  • Mycobacterium bovis / isolation & purification
  • Pneumonia / complications
  • Pneumonia / diagnosis*
  • Pneumonia / etiology
  • Tuberculoma / diagnosis*
  • Tuberculoma / etiology
  • Tuberculoma / prevention & control

Substances

  • Antitubercular Agents
  • BCG Vaccine